All In Biotech

Free tool

FAERS Monitor: Carnitor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018948 or its brand name (Carnitor, Levocarnitine). Reports on generic versions are filed under their own applications.

Reports

3,646

Serious

2,818

77% of reports

Hospitalization

1,713

Death reported

395

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure391
  • off label use309
  • vomiting230
  • diarrhoea210
  • drug ineffective195
  • fatigue185
  • pneumonia182
  • pyrexia174
  • nausea135
  • product dose omission issue133
  • somnolence131
  • decreased appetite123
  • death120
  • dyspnoea106
  • headache92

Reports by year received

View as table
YearReports
200423
200517
200612
200728
200853
200932
201030
201134
201257
201371
201480
2015124
2016226
2017159
2018195
2019228
2020271
2021255
2022356
2023411
2024408
2025353
2026223

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,513 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal39119.617.86,894
somnolenceSignal1313.83.2264
pneumoniaSignal1823.22.8285
decreased appetiteSignal1233.12.6170
pyrexiaSignal1742.92.5218
vomitingSignal2302.82.5275
product dose omission issueSignal1332.62.2132
off label useSignal3092.01.8169
diarrhoea2101.91.688
fatigue1851.41.219
dyspnoea1061.10.91
nausea1351.00.80
drug ineffective1950.90.75
headache920.80.72
death1200.80.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.